News

news-preview-placeholder
New Rule for Hydrocodone

The U. S. Drug Enforcement Agency (DEA) has published its final rule for hydrocodone combination…

Aug 22, 2014
news-preview-placeholder
OTC Flonase Expected to Be Available in Early 2015

The FDA has recently approved Flonase Allergy Relief to be an OTC treatment for temporary…

Aug 06, 2014
news-preview-placeholder
Louisiana: Carisoprodol (Soma) Placed in Schedule II Classification

Act 397 (SB 618) of 2014 Legislature – effective August 1. 2014. This law places…

Jul 23, 2014
news-preview-placeholder
FDA Approves New Extended-Release Oxycodone with Abuse-Deterrent Properties

“Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride…

news-preview-placeholder
Launch of Generic Diovan

The generic equivalent of Diovan (valsartan) has just been released, following FDA approval. Diovan is…

Jul 07, 2014
news-preview-placeholder
Re-Launch of Generic Astepro

The generic equivalent of Astepro (azelastine) has just been re-launched, following FDA approval. Astepro is…

news-preview-placeholder
DEA Finalizes Rule to Schedule Tramadol

On July 2, 2014, the Drug Enforcement Administration (DEA) published in the Federal Register the…

Jul 02, 2014
news-preview-placeholder
Launch of Generic Testim® 1% gel

The generic equivalent of Testim® 1% gel (testosterone gel) has just been released, following FDA…

Jun 11, 2014
news-preview-placeholder
Launch of Generic Actonel 150mg

The generic equivalent of Actonel 150mg (risendronate sodium tablets) has just been released, following FDA…

news-preview-placeholder
Launch of Generic Pennsaid 1.5%

The generic equivalent of Pennsaid 1.5% (diclofenac sodium topical solution) has just been released, following…

May 29, 2014
  • This field is for validation purposes and should be left unchanged.


Filter Articles

Should a claimant need this much pain medication for this long? Are claimants utilizing medications or selling on the black market?

The prevalence of opioid use and abuse among those with chronic pain has developed into one of the most pressing issues today. Download the white paper to learn facts about the opioid crisis and possible solutions to avoid prescriptions that could lead to abuse.

Download Now